id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-2782-0004,FDA,FDA-2022-N-2782,"Antimicrobial Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket;
Request for Comments",Notice,Request for Comments,2023-02-27T05:00:00Z,2023,2,2023-02-27T05:00:00Z,2023-03-16T03:59:59Z,2023-03-16T01:01:14Z,2023-03971,0,0,090000648571b832
FDA-2022-N-2782-0001,FDA,FDA-2022-N-2782,Antimicrobial Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,Notice,Request for Comments,2022-11-25T05:00:00Z,2022,11,2022-11-25T05:00:00Z,2023-01-24T04:59:59Z,2023-01-04T02:00:57Z,2022-25643,0,0,0900006485500677